157 related articles for article (PubMed ID: 6764117)
1. [Effect of lentinan administration of adrenalectomized rats and patients with breast cancer].
Kosaka A; Wani T; Hattori Y; Yamashita A
Gan To Kagaku Ryoho; 1982 Aug; 9(8):1474-81. PubMed ID: 6764117
[TBL] [Abstract][Full Text] [Related]
2. [Effects of lentinan in advanced or recurrent cases of gastric, colorectal, and breast cancer].
Taguchi T
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):387-93. PubMed ID: 6349538
[TBL] [Abstract][Full Text] [Related]
3. [Cumulative effects of lentinan and endocrine therapy on the growth of DMBA-induced mammary tumor in rats].
Kosaka A; Imaizumi A; Hatori Y; Mori F; Wani T; Yamashita A
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1399-407. PubMed ID: 6430243
[TBL] [Abstract][Full Text] [Related]
4. [Results of phase III study of lentinan].
Taguchi T; Furue H; Kimura T; Kondo T; Hattori T; Itoh I; Ogawa N
Gan To Kagaku Ryoho; 1985 Feb; 12(2):366-78. PubMed ID: 3918510
[TBL] [Abstract][Full Text] [Related]
5. [Synergistic action of lentinan (LNT) with endocrine therapy of breast cancer in rats and humans].
Kosaka A; Kuzuoka M; Yamafuji K; Imaizumi A; Hattori Y; Yamashita A
Gan To Kagaku Ryoho; 1987 Feb; 14(2):516-22. PubMed ID: 3101609
[TBL] [Abstract][Full Text] [Related]
6. Recent progress in immunopharmacology and therapeutic effects of polysaccharides.
Chihara G
Dev Biol Stand; 1992; 77():191-7. PubMed ID: 1426662
[TBL] [Abstract][Full Text] [Related]
7. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group.
Nakano H; Namatame K; Nemoto H; Motohashi H; Nishiyama K; Kumada K
Hepatogastroenterology; 1999; 46(28):2662-8. PubMed ID: 10522061
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of lentinan on patients with stomach cancer: end point results of a four-year follow-up survey.
Taguchi T
Cancer Detect Prev Suppl; 1987; 1():333-49. PubMed ID: 3121179
[TBL] [Abstract][Full Text] [Related]
9. [Effect of lentinan for advanced prostate carcinoma].
Tari K; Satake I; Nakagomi K; Ozawa K; Oowada F; Higashi Y; Negishi T; Yamada T; Saito H; Yoshida K
Hinyokika Kiyo; 1994 Feb; 40(2):119-23. PubMed ID: 8128920
[TBL] [Abstract][Full Text] [Related]
10. [Combined use of lentinan with X-ray therapy in an experimental mouse tumor system (Part 2). Combined effect on the MM102 syngeneic tumor].
Shiio T; Ohishi K; Tsuchiya Y; Niitsu I; Hayashibara H; Yoshihama T; Moriyuki H
Gan To Kagaku Ryoho; 1988 Mar; 15(3):475-9. PubMed ID: 3348633
[TBL] [Abstract][Full Text] [Related]
11. Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulator: an overview.
Chihara G; Hamuro J; Maeda YY; Shiio T; Suga T; Takasuka N; Sasaki T
Cancer Detect Prev Suppl; 1987; 1():423-43. PubMed ID: 3319150
[TBL] [Abstract][Full Text] [Related]
12. [Antitumor effect of polysaccharide lentinan on C3H/He mice bearing MH134 ascites hepatoma].
Moriyama M; Miwa H; Moriya N; Orita K
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1102-7. PubMed ID: 6820909
[TBL] [Abstract][Full Text] [Related]
13. [Age-dependent anti-tumor activity of lentinan in mice].
Shiio T; Yoshihama T; Tsuchiya Y; Yugari Y
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2300-4. PubMed ID: 3606149
[TBL] [Abstract][Full Text] [Related]
14. [Antitumor effect of bacterial lipopolysaccharide (LPS) and a combination use of LPS and lentinan on C3H/He mice bearing MH-134 tumor].
Moriya N; Miwa H; Taketsuka S; Orita K
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1646-52. PubMed ID: 6870308
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of oral administered superfine dispersed lentinan for advanced pancreatic cancer.
Shimizu K; Watanabe S; Watanabe S; Matsuda K; Suga T; Nakazawa S; Shiratori K
Hepatogastroenterology; 2009; 56(89):240-4. PubMed ID: 19453066
[TBL] [Abstract][Full Text] [Related]
16. [TS-1/CDDP/Lentinan combination chemotherapy for inoperable advanced gastric cancer].
Nagahashi S; Suzuki H; Nishiwaki M; Okuda K; Kurosawa Y; Terada S; Sugihara T; Andou K; Hibi T
Gan To Kagaku Ryoho; 2004 Nov; 31(12):1999-2003. PubMed ID: 15570928
[TBL] [Abstract][Full Text] [Related]
17. Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancer.
Oba K; Kobayashi M; Matsui T; Kodera Y; Sakamoto J
Anticancer Res; 2009 Jul; 29(7):2739-45. PubMed ID: 19596954
[TBL] [Abstract][Full Text] [Related]
18. [Usefulness of TS-1 and lentinan combination immunochemotherapy in advanced or recurrent gastric cancer--pilot study aiming at a randomized trial].
Kimura Y; Iijima S; Kato T; Tsujie M; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E; Kikkawa N; Matsuura N
Gan To Kagaku Ryoho; 2003 Aug; 30(8):1125-30. PubMed ID: 12938267
[TBL] [Abstract][Full Text] [Related]
19. Combined effect of cyclocytidine and lentinan of spontaneous mammary tumors in mice.
Tokuzen R; Okabe M; Nakahara LW
Gan; 1976 Apr; 67(2):327-9. PubMed ID: 964561
[TBL] [Abstract][Full Text] [Related]
20. [Effects of endoscopic intratumoral injection of lentinan in patients with gastric cancer].
Inagaki T; Morise K; Matsunaga H
Gan To Kagaku Ryoho; 1988 Feb; 15(2):319-24. PubMed ID: 3257678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
